237 related articles for article (PubMed ID: 14612495)
1. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.
Lu F; Gladden AB; Diehl JA
Cancer Res; 2003 Nov; 63(21):7056-61. PubMed ID: 14612495
[TBL] [Abstract][Full Text] [Related]
2. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.
Benzeno S; Lu F; Guo M; Barbash O; Zhang F; Herman JG; Klein PS; Rustgi A; Diehl JA
Oncogene; 2006 Oct; 25(47):6291-303. PubMed ID: 16732330
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.
Solomon DA; Wang Y; Fox SR; Lambeck TC; Giesting S; Lan Z; Senderowicz AM; Conti CJ; Knudsen ES
J Biol Chem; 2003 Aug; 278(32):30339-47. PubMed ID: 12746453
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68.
Paronetto MP; Cappellari M; Busà R; Pedrotti S; Vitali R; Comstock C; Hyslop T; Knudsen KE; Sette C
Cancer Res; 2010 Jan; 70(1):229-39. PubMed ID: 20028857
[TBL] [Abstract][Full Text] [Related]
6. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.
Olshavsky NA; Comstock CE; Schiewer MJ; Augello MA; Hyslop T; Sette C; Zhang J; Parysek LM; Knudsen KE
Cancer Res; 2010 May; 70(10):3975-84. PubMed ID: 20460515
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome.
Abramson VG; Troxel AB; Feldman M; Mies C; Wang Y; Sherman L; McNally S; Diehl A; Demichele A
Anticancer Res; 2010 Apr; 30(4):1279-85. PubMed ID: 20530440
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines.
Kitahara K; Yasui W; Yokozaki H; Semba S; Hamamoto T; Hisatsugu T; Tahara E
J Exp Ther Oncol; 1996 Jan; 1(1):7-12. PubMed ID: 9414383
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation.
Alt JR; Cleveland JL; Hannink M; Diehl JA
Genes Dev; 2000 Dec; 14(24):3102-14. PubMed ID: 11124803
[TBL] [Abstract][Full Text] [Related]
11. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
12. Alternate cyclin D1 mRNA splicing modulates p27KIP1 binding and cell migration.
Li Z; Wang C; Jiao X; Katiyar S; Casimiro MC; Prendergast GC; Powell MJ; Pestell RG
J Biol Chem; 2008 Mar; 283(11):7007-15. PubMed ID: 18180298
[TBL] [Abstract][Full Text] [Related]
13. Alternative cyclin D1 forms a and b have different biological functions in the cell cycle of B lymphocytes.
Lévêque C; Marsaud V; Renoir JM; Sola B
Exp Cell Res; 2007 Jul; 313(12):2719-29. PubMed ID: 17499716
[TBL] [Abstract][Full Text] [Related]
14. Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b).
Rojas P; Benavides F; Blando J; Perez C; Cardenas K; Richie E; Knudsen ES; Johnson DG; Senderowicz AM; Rodriguez-Puebla ML; Conti CJ
Mol Carcinog; 2009 Jun; 48(6):508-16. PubMed ID: 18942117
[TBL] [Abstract][Full Text] [Related]
15. Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness.
Kim CJ; Terado T; Tambe Y; Mukaisho KI; Sugihara H; Kawauchi A; Inoue H
Int J Oncol; 2018 Jan; 52(1):231-240. PubMed ID: 29115414
[TBL] [Abstract][Full Text] [Related]
16. PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b.
Meng H; Tian L; Zhou J; Li Z; Jiao X; Li WW; Plomann M; Xu Z; Lisanti MP; Wang C; Pestell RG
Cell Cycle; 2011 Jan; 10(1):73-81. PubMed ID: 21200149
[TBL] [Abstract][Full Text] [Related]
17. Female-specific rectal carcinogenesis in cyclin D1b transgenic mice.
Kim CJ; Tambe Y; Mukaisho K; Sugihara H; Isono T; Sonoda H; Shimizu T; Kondoh G; Inoue H
Carcinogenesis; 2014 Jan; 35(1):227-36. PubMed ID: 23975835
[TBL] [Abstract][Full Text] [Related]
18. Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma.
Gupta VK; Feber A; Xi L; Pennathur A; Wu M; Luketich JD; Godfrey TE
Clin Cancer Res; 2008 Dec; 14(23):7804-12. PubMed ID: 19047108
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing variants of human Fbx4 disturb cyclin D1 proteolysis in human cancer.
Chu X; Zhang T; Wang J; Li M; Zhang X; Tu J; Sun S; Chen X; Lu F
Biochem Biophys Res Commun; 2014 Apr; 447(1):158-64. PubMed ID: 24704453
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
Yu B; Lane ME; Pestell RG; Albanese C; Wadler S
Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
